Penumbra Inc.   Report issue

For profit Phase 4
Founded: Alameda CA United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2012
NCT01429350
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Penumbra Inc.